Introduction to ART – October 2019
This widely used guide to HIV treatment (ART) has been updated. It is available as a printed A5 booklet that is also available online.
Main changes to this 2019 edition are to update the choice of drugs, to include the most current treatment guidelines and add new information about recently approved drugs. So both the text and drug chart (the pull-out centre pages or separate PDF) includes bictegravir, Biktarvy, doravirine, Delstrigo, Dovato and ibalizumab.
This is the 24th edition of this guide. i-Base set out to make information clear, easy to understand and direct. We update this guide every 12 to 18 months because treatment and the way it us used still changes – though not as quickly as for early editions.
UK guidelines have for many years recommended that treatment should be reviewed annually and we think that information for people living with HIV should match this too.
Also, all i-Base resources (booklets, leaflets, U=U posters and cards, questions to the information service and UK-CAB membership) remain free to UK clinics. This follows the model of NHS care based on universal healthcare as a right.
i-Base guides aim to help you understand your treatment choices, to encourage you to ask questions, and to have better health and better quality of life.
Thanks as always to the advisory group that have added comments each year, making this a collaboration between treatment advocates (many of who are living with HIV) and health workers.